See RE; Chapman MA; Murray CE; Aravagiri M. Regional differences in chronic
neuroleptic effects on extracellular dopamine activity. Brain Research Bulletin, 1992
Sep-Oct, 29(3-4):473-8.
Marder SR; Midha KK; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J.
Plasma levels of fluphenazine in patients receiving fluphenazinedecanoate. Relationship to
clinical response [see comments]. British Journal of Psychiatry, 1991 May, 158:658-65.
Van Putten T; Aravagiri M; Marder SR; Wirshing WC; Mintz J; Chabert N. Plasma fluphenazine
levels and clinical response in newly admitted schizophrenic patients. Psychopharmacology
Bulletin, 1991, 27(2):91-6.
Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N. Neuroleptic plasma levels.
Schizophrenia Bulletin, 1991, 17(2):197-216.
Van Putten T; Marder SR; Wirshing WC; Chabert N; Aravagiri M. Surreptitious noncompliance
with oral fluphenazine in a voluntary inpatient population [letter]. Archives of General
Psychiatry, 1990 Aug, 47(8):786-7.
Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Hubbard JW; Midha KK. Therapeutic
monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in
chronically treated schizophrenic patients determined by a specific and sensitive
radioimmunoassay. Therapeutic Drug Monitoring, 1990 May, 12(3):268-76.
Aravagiri M; Marder SR; van Putten T. Determination of plasma homovanillic acid by column
liquid chromatography with electrochemical detection. Journal of Chromatography, 1990 Feb
23, 525(2):419-25.
Marder SR; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J; Midha KK.
Fluphenazine plasma levels and clinical response. Psychopharmacology Bulletin, 1990,
26(2):256-9.
Aravagiri M; Ames D; Wirshing WC; Marder SR. Plasma level monitoring of olanzapine in
patients with schizophrenia: determination by high-performance liquid chromatography with
electrochemical detection. Therapeutic Drug Monitoring, 1997 Jun, 19(3):307-13.
See RE; Lynch AM; Aravagiri M; Nemeroff CB; Owens MJ. Chronic haloperidol-induced changes
in regional dopamine release and metabolism and neurotensin content in rats. Brain
Research, 1995 Dec 18, 704(2):202-9.
Aravagiri M; Marder SR; Yuwiler A; Midha KK; Kula NS; Baldessarini RJ. Distribution of
fluphenazine and its metabolites in brain regions and other tissues of the rat.
Neuropsychopharmacology, 1995 Nov, 13(3):235-47.
Merchant KM; Dobie DJ; Filloux FM; Totzke M; Aravagiri M; Dorsa DM. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. Journal of Pharmacology and Experimental Therapeutics, 1994 Oct, 271(1):460-71.
Aravagiri M; Marder SR; Van Putten T; Marshall BD. Simultaneous determination of
plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with
electrochemical detection. Plasma levels in schizophrenic patients treated with oral or
intramuscular depot haloperidol. Journal of Chromatography. B, Biomedical Applications,
1994 Jun 17, 656(2):373-81.
Liberman RP; Van Putten T; Marshall BD Jr; Mintz J; Bowen L; Kuehnel TG; Aravagiri M;
Marder SR. Optimal drug and behavior therapy for treatment-refractory schizophrenic
patients. American Journal of Psychiatry, 1994 May, 151(5):756-9.
Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK. Radioimmunoassay for
7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in
schizophrenic patients treated long term with oral and depot fluphenazine. Therapeutic
Drug Monitoring, 1994 Feb, 16(1):21-9.
Hubbard JW; Midha KK; Hawes EM; McKay G; Marder SR; Aravagiri M; Korchinski ED. Metabolism
of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research
findings and clinical implications. British Journal of Psychiatry. Supplement, 1993
Dec(22):19-24.
Midha KK; Marder SR; Jaworski TJ; McKay G; Hubbard JW; Hawes EM; Van Putten T; Wirshing
WC; Aravagiri M. Clinical perspectives of some neuroleptics through development and
application of their assays. Therapeutic Drug Monitoring, 1993 Jun, 15(3):179-89.
Aravagiri M; Marder SR; Van Putten T; Midha KK. Determination of risperidone in plasma by
high-performance liquid chromatography with electrochemical detection: application to
therapeutic drug monitoring in schizophrenic patients. Journal of Pharmaceutical Sciences,
1993 May, 82(5):447-9.
Bartzokis G; Aravagiri M; Oldendorf WH; Mintz J; Marder SR. Field dependent transverse
relaxation rate increase may be a specific measure of tissue iron stores. Magnetic
Resonance in Medicine, 1993 Apr, 29(4):459-64.
Jaworski TJ; Sardessai MS; Aravagiri M; Lin G; Shi YY; Hawes EM; Hubbard JW; McKay G;
Midha KK. Synthesis of the N-oxides of phenothiazine antipsychotic agents. Journal of
Pharmaceutical Sciences, 1993 Mar, 82(3):330-3.
Van Putten T; Marshall BD; Liberman R; Mintz J; Kuehnel TG; Bowen L; Aravagiri M; Marder
SR. Systematic dosage reduction in treatment-resistant schizophrenic patients.
Psychopharmacology Bulletin, 1993, 29(2):315-20.
